l-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson's disease-Reference-Cited by-同舟云学术

l-Dopa release from mesoporous silica nanoparticles engineered through the concept of drug-structure-directing agents for Parkinson's disease

Published:2021 Issue:20 Volume:9 Page:4178-4189
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Morales V.¹²³⁴,McConnell J.⁵⁶⁷⁸,Pérez-Garnes M.¹²³⁴,Almendro N.¹²³⁴,Sanz R.¹²³⁴^ORCID,García-Muñoz R. A.¹²³⁴^ORCID

Affiliation:

1. Department of Chemical and Environmental Technology

2. Rey Juan Carlos University

3. Móstoles

4. Spain

5. Department of Chemical & Process Engineering

6. University of Strathclyde

7. Glasgow G1 1XJ

8. UK

Abstract

l-Dopa@MSNs based on the concept of drug-structure-directing agents were successfully prepared and proved to be programmed oral l-Dopa release nanosystem pH responsive for the treatment of Parkinson's disease.

Funder

Ministerio de Ciencia e Innovación

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB00481F

Reference52 articles.

1. UNESCO, “Media Services,” UNESCO, 12 07 2016. [Online]. Available: http://www.unesco.org/new/en/media-services/single-view/news/nanotechnology_is_a_growing_research_priority/ [accessed 12 02 2020]

2. Global Innovation Index, “Global Innovation Index 2019: Creating Healthy Lives – The Future of Medical Innovation,” Global Innovation Index, 2019

3. Grand View Research, “Nanomedicine Market Analysis By Products, (Therapeutics, Regenerative Medicine, Diagnostics), By Application, (Clinical Oncology, Infectious diseases), By Nanomolecule (Gold, Silver, Iron Oxide, Alumina), & Segment Forecasts, 2018–2025,” Grand View Research, 2017

4. S. M. P. Anu Mary Ealias , A review on the classification, characterisation, synthesis of nanoparticles and their application , in IOP Conference Series: Materials Science and Engineering , 2017

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-ınduced Parkinson’s disease;Scientific Reports;2024-08-17

2. Interaction between resveratrol and SIRT1: role in neurodegenerative diseases;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-06

3. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction;Molecules;2024-07-29

4. Selenium Nanoparticles as Neuroprotective Agents: Insights into Molecular Mechanisms for Parkinson’s Disease Treatment;Molecular Neurobiology;2024-06-05

5. Mitoxantrone-Derivative Drug Structure-Directing Agent for the Synthesis of Magnetic Mesoporous Silica Nanoparticles for Breast Cancer Treatment;ACS Applied Nano Materials;2024-05-20